Myeloma Matters – Winter 2015
In this issue:
Dr Matthew Jenner explains how high-risk myeloma is currently identified, defined and treated and how this might be different in the future.
Chairman of the Scottish Medicines Consortium (SMC), Prof Jonathan Fox, talks about the work of the SMC and the recent reforms that have been made to the way it operates.
This article explains what radiotherapy is, how and why it’s given, possible side-effects and its future use as a myeloma treatment.
Living well with myeloma
This regular feature looks at coping with peripheral neuropathy, gives some practical tips for managing fatigue and discusses mindfulness and myeloma.
Peter Martin talks about when he was diagnosed with myeloma in 2003, the treatment he has received and the effect the diagnosis has had on his life.